These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22329719)

  • 1. Factor XIII plasma levels in women with unexplained recurrent pregnancy loss.
    Pasquier E; De Saint Martin L; Kohler HP; Schroeder V
    J Thromb Haemost; 2012 Apr; 10(4):723-5. PubMed ID: 22329719
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the functional VEGFA-583C/T variant on vascular endothelial growth factor levels and the risk of recurrent spontaneous miscarriage.
    Al-Khateeb GM; Mustafa FE; Sater MS; Almawi WY
    Fertil Steril; 2011 Jun; 95(8):2471-3. PubMed ID: 21458805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum amyloid A level as a novel marker of primary unexplained recurrent early pregnancy loss.
    Ibrahim MI; Ramy AR; Abdelhamid AS; Ellaithy MI; Omar A; Harara RM; Fathy H; Abolouz AS
    Int J Gynaecol Obstet; 2017 Mar; 136(3):298-303. PubMed ID: 28099717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating Association of Three Polymorphisms of Coagulation Factor XIII and Recurrent Pregnancy Loss.
    Jeddi-Tehrani M; Torabi R; Mohammadzadeh A; Arefi S; Keramatipour M; Zeraati H; Zarnani AH; Akhondi MM; Mahmoudian J; Mahmoudi AR; Zarei S
    Am J Reprod Immunol; 2010 Sep; 64(3):212-7. PubMed ID: 20384622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
    Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy.
    Dargaud Y; de Mazancourt P; Rugeri L; Hanss M; Borg JY; Gaucherand P; Negrier C; Trzeciak C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):447-52. PubMed ID: 18600098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could platelet distribution width be a predictive marker for unexplained recurrent miscarriage?
    Mete Ural U; Bayoğlu Tekin Y; Balik G; Kir Şahin F; Colak S
    Arch Gynecol Obstet; 2014 Aug; 290(2):233-6. PubMed ID: 24619190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with Recombinant Factor XIII (Tretten) in a Pregnant Woman with Factor XIII Deficiency.
    Abdel-Samad N
    Am J Case Rep; 2017 Apr; 18():436-439. PubMed ID: 28432284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Z variants associated with protein Z plasma levels and with risk of idiopathic recurrent miscarriage.
    Al-Shaikh FS; Sater MS; Finan RR; Racoubian E; Abu-Hijleh TM; Mustafa FE; Almawi WY
    Reprod Sci; 2013 Sep; 20(9):1062-8. PubMed ID: 23420821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values?
    Trout SW; Seifer DB
    Fertil Steril; 2000 Aug; 74(2):335-7. PubMed ID: 10927054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.
    Dossenbach-Glaninger A; van Trotsenburg M; Oberkanins C; Atamaniuk J
    J Clin Lab Anal; 2013 Nov; 27(6):444-9. PubMed ID: 24218126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of reduced selenium status in the aetiology of recurrent miscarriage.
    Nicoll AE; Norman J; Macpherson A; Acharya U
    Br J Obstet Gynaecol; 1999 Nov; 106(11):1188-91. PubMed ID: 10549965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticardiolipin antibodies in women with recurrent abortion.
    Daboubi MK
    East Mediterr Health J; 2001; 7(1-2):95-9. PubMed ID: 12596957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage.
    Ogasawara MS; Aoki K; Katano K; Ozaki Y; Suzumori K
    Fertil Steril; 2001 May; 75(5):916-9. PubMed ID: 11334902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.
    Younis JS; Brenner B; Ohel G; Tal J; Lanir N; Ben-Ami M
    Am J Reprod Immunol; 2000 Jan; 43(1):31-5. PubMed ID: 10698038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure.
    Sauer R; Roussev R; Jeyendran RS; Coulam CB
    Fertil Steril; 2010 May; 93(7):2441-3. PubMed ID: 19962695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion.
    Kruse C; Rosgaard A; Steffensen R; Varming K; Jensenius JC; Christiansen OB
    Am J Obstet Gynecol; 2002 Nov; 187(5):1313-20. PubMed ID: 12439525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage.
    Coulam CB; Jeyendran RS; Fishel LA; Roussev R
    Am J Reprod Immunol; 2006 May; 55(5):360-8. PubMed ID: 16635210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent spontaneous abortion and selenium deficiency.
    Koçak I; Aksoy E; Ustün C
    Int J Gynaecol Obstet; 1999 Apr; 65(1):79-80. PubMed ID: 10390108
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein Z levels and recurrent pregnancy loss.
    Effraimidou S; Farmakiotis D; Topalidou M
    Fertil Steril; 2009 May; 91(5):e27; author reply e28. PubMed ID: 19268937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.